DK150141C - Analogifremgangsmaade til fremstilling af n-(2-thiazolyl)-amider - Google Patents

Analogifremgangsmaade til fremstilling af n-(2-thiazolyl)-amider

Info

Publication number
DK150141C
DK150141C DK165779A DK165779A DK150141C DK 150141 C DK150141 C DK 150141C DK 165779 A DK165779 A DK 165779A DK 165779 A DK165779 A DK 165779A DK 150141 C DK150141 C DK 150141C
Authority
DK
Denmark
Prior art keywords
thiazolyl
analogue
amides
preparation
Prior art date
Application number
DK165779A
Other languages
Danish (da)
English (en)
Other versions
DK150141B (da
DK165779A (da
Inventor
Charles Armon Harbert
Joseph George Lombardino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK165779A publication Critical patent/DK165779A/da
Publication of DK150141B publication Critical patent/DK150141B/da
Application granted granted Critical
Publication of DK150141C publication Critical patent/DK150141C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/121,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK165779A 1978-04-24 1979-04-23 Analogifremgangsmaade til fremstilling af n-(2-thiazolyl)-amider DK150141C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/899,065 US4217355A (en) 1978-04-24 1978-04-24 Amide therapeutic agents
US89906578 1978-04-24

Publications (3)

Publication Number Publication Date
DK165779A DK165779A (da) 1979-10-25
DK150141B DK150141B (da) 1986-12-15
DK150141C true DK150141C (da) 1987-06-01

Family

ID=25410439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK165779A DK150141C (da) 1978-04-24 1979-04-23 Analogifremgangsmaade til fremstilling af n-(2-thiazolyl)-amider

Country Status (6)

Country Link
US (1) US4217355A (ko)
EP (1) EP0005070B1 (ko)
JP (1) JPS54154764A (ko)
DE (1) DE2961537D1 (ko)
DK (1) DK150141C (ko)
IE (1) IE48740B1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
EP0068033B1 (en) * 1981-01-08 1985-07-10 Mitsui Toatsu Kagaku Kabushiki Kaisha N-(4-phenyl-2-thiazolyl)carbamate derivatives, process for their preparation, and medicinal composition containing same
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
US4501750A (en) * 1981-01-13 1985-02-26 Mitsui Toatsu Kaguku Kabushiki Kaisha Thiazole compounds, a process for preparing same and a pharmaceutical composition containing the thiazole compounds
WO1982002386A1 (en) * 1981-01-13 1982-07-22 Sakano Isao Aminothiazole derivatives,process for their preparation,and medicinal composition containing same
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物
JPH07502014A (ja) * 1991-06-21 1995-03-02 ベーリンガー マンハイム イタリア エス.ピー.エイ. 気道に対して抗喘息性、抗炎症性活性を有する2−アミノ−4−アリール−チアゾール
JP4783774B2 (ja) * 1996-08-12 2011-09-28 田辺三菱製薬株式会社 Rhoキナーゼ阻害剤を含有する医薬
US7384968B2 (en) 2004-04-01 2008-06-10 Pfizer Inc. Thiazole-amine compounds for the treatment of neurodegenerative disorders
CN101445492B (zh) * 2008-12-16 2012-05-30 天津药物研究院 酰胺基噻唑衍生物、其制备方法和用途
DE102011083283A1 (de) * 2011-09-23 2013-03-28 Beiersdorf Ag Heteroalkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Heteroalkylamidothiazolen
DE102013226711A1 (de) * 2013-12-19 2015-06-25 Beiersdorf Ag Verwendung von Alkylamidothiazolen in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR716M (ko) * 1960-08-05 1961-08-07
US3862167A (en) * 1965-08-11 1975-01-21 Mitsui Toatsu Chemicals Certain 2-acylamine-4-methyl-5-halothiazoles
GB1290841A (ko) * 1968-07-05 1972-09-27
US3553227A (en) * 1968-08-05 1971-01-05 Parke Davis & Co S-2-((2-(2-thiazolylcarbamoyl)ethyl)amino)ethyl thiosulfate, salts thereof, and methods for their production
FR2092714B1 (ko) * 1970-06-11 1974-03-22 Melle Bezons
US3853862A (en) * 1973-04-23 1974-12-10 Pfizer Production of 4-hydroxy-1,2-benzothiazine-3-carboxamides
GB1440212A (en) * 1973-08-29 1976-06-23 Phavic Sprl Derivatives of 2-phenoxyacetamido-5-nitrothiazoles
HU168776B (ko) * 1973-11-09 1976-07-28

Also Published As

Publication number Publication date
US4217355A (en) 1980-08-12
IE790819L (en) 1979-10-24
EP0005070A2 (en) 1979-10-31
JPS54154764A (en) 1979-12-06
EP0005070A3 (en) 1979-11-28
IE48740B1 (en) 1985-05-01
DK150141B (da) 1986-12-15
EP0005070B1 (en) 1981-12-09
JPS6157306B2 (ko) 1986-12-06
DK165779A (da) 1979-10-25
DE2961537D1 (en) 1982-02-04

Similar Documents

Publication Publication Date Title
DK150068C (da) Analogifremgangsmaade til fremstilling af aminothiazoler
DK148141C (da) Analogifremgangsmaade til fremstilling af phosphonylacetylproliner
DK523579A (da) Fremgangsmaade til fremstilling af aminosyrederivater
DK372479A (da) Fremgangsmaade til fremstilling af aminosyrederivater
DK155048C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinforbindelser
DK156001C (da) Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner
DK158269C (da) Analogifremgangsmaade til fremstilling af morpholinyldaunorubicin- eller morpholinyldoxorubicinderivater
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
DK150141C (da) Analogifremgangsmaade til fremstilling af n-(2-thiazolyl)-amider
DK146542C (da) Analogifremgangsmaade til fremstilling af daunosaminylanthracyclioner
DK158836C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater
DK540180A (da) Fremgangsmaade til fremstilling af acetamider
DK533979A (da) Fremgangsmaade til fremstilling af thiazolylderivater
DK185579A (da) Fremgangsmaade til fremstilling af n-(benzothienopyrazol)amider
DK113079A (da) Fremgangsmaade til fremstilling af n-oxacyclylalkyl-piperidyl-diazaforbindelser og anvendelsen deraf
DK158460C (da) Analogifremgangsmaade til fremstilling af substituerede oxocarboxylsyrer
DK489279A (da) Fremgangsmaade til fremstilling af aminderivater
DK147854C (da) Analogifremgangsmaade til fremstilling af n-(1-benzylpiperid-4-yl)-benzamider
DK137956B (da) Analogifremgangsmaade til fremstilling af andazolyl-(4)-oxy-propanolaminderivater
DK156431C (da) Analogifremgangsmaade til fremstilling af n-substituerede 2-cyanaziridiner
ES487148A0 (es) Procedimiento de preparacion de nuevas trifluoroetilaminas n-sustituidas
DK146718C (da) Analogifremgangsmaade til fremstilling af benzobicyklononener
DK160560C (da) Analogifremgangsmaade til fremstilling af acetyleniske derivater af androstenforbindelser samt mellemprodukt til brug derved
DK1080A (da) Fremgangsmaade til fremstilling af aminer
DK143558C (da) Analogifremgangsmaade til fremstilling af n-substituerede (4-chlor-6-(2,3-xylidino)-2-pyrimidinyl-thio)acetamider

Legal Events

Date Code Title Description
PBP Patent lapsed